Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma. Implications for staging and prognosis-Reference-Cited by-同舟云学术

Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma. Implications for staging and prognosis

Published:2013-12-06 Issue:5 Volume:67 Page:431-436
ISSN:0021-9746
Container-title:Journal of Clinical Pathology
language:en
Short-container-title:J Clin Pathol

Author:

Horna Pedro,Deaver Darcie M,Qin Dahui,Moscinski Lynn C,Sotomayor Eduardo M,Glass L Frank,Sokol Lubomir

Publisher

BMJ

Subject

General Medicine,Pathology and Forensic Medicine

Reference26 articles.

1. WHO-EORTC classification for cutaneous lymphomas;Willemze;Blood,2005

2. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas;Vonderheid;JAMA,2002

3. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization for Research and Treatment of Cancer (EORTC);Olsen;Blood,2007

4. Sezary cell counts in erythrodermic cutaneous T-cell lymphoma: implications for prognosis and staging;Vonderheid;Leuk Lymphoma,2006

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of the median fluorescence intensity of CD3 and CD4 in mycosis fungoides/Sezary syndrome versus non-neoplastic control cases in peripheral blood;Journal of Hematopathology;2024-08-02

2. Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry;Blood Cancer Journal;2024-02-29

3. Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry;2023-12-08

4. Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry;2023-12-01

5. Peripheral Blood Involvement at Staging in Patients With Aggressive Peripheral T-Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2022-09